Rapid Fire Abstracts
Marilena Giannoudi, MRes(Hons), MSc, MRCP, FHEA
Cardiology Research Fellow
University of Leeds, United Kingdom
Marilena Giannoudi, MRes(Hons), MSc, MRCP, FHEA
Cardiology Research Fellow
University of Leeds, United Kingdom
Henry Procter, MBChB
Cardiology research fellow
University of Leeds, United Kingdom
Sindhoora Kotha, BSc, MB
Cardiology Clinical Research Fellow
University of Leeds, Multidisciplinary Cardiovascular Research Centre and Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, LS2 9JT, United Kingdom, United Kingdom
Nicholas Jex, PhD
Cardiology Research Fellow
University of Leeds, United Kingdom
Richard Cubbon, PhD
Associate Professor
University of Leeds, United Kingdom
Marc R. Dweck, MD, PhD
Professor of Clinical Cardiology
University of Edinburgh, United Kingdom
John Greenwood, MBChB, PhD, FRCP, FSCMR, FACC, FESC, FBCS, FICS
Professor/Director
Baker Heart and Diabetes Institute
Melbourne University, Australia
Peter Kellman, PhD
Director of the Medical Signal and Image Processing Program
National Heart, Lung, and Blood Institute, National Institutes of Health
Eylem Levelt, PhD
Professor of Cardiology
The Baker Heart and Diabetes Institute , Australia
Aim: Aortic stenosis (AS) accounts for substantial global morbidity and premature mortality even in moderate AS (Mod-AS). The rate of myocardial remodeling progression in patients with mod-AS is unclear.
Methods:
Methods: Twenty-five Mod-AS patients were prospectively recruited and followed up for a period of 18 months to assess the progression of the degree of valvular stenosis as well as myocardial remodeling. Patients underwent a baseline cardiovascular magnetic resonance (CMR) at baseline to define left ventricular (LV) concentricity (LV-mass/LV-end-diastolic-volume), global longitudinal shortening (GLS), mitral inflow E/A ratio, rest and adenosine-stress myocardial blood flow (MBF), myocardial perfusion reserve (MPR), layer-specific perfusion metrics (subendocardial [Endo], subepicardial [Epi] MBF and MPR, and Endo- to Epi-MBF ratio [Endo/Epi]), tissue characterization (late gadolinium enhancement imaging [LGE]) at baseline. Identical follow-up CMR scans were performed at 12 months in 18 patients.
Results:
Results: Compared to baseline visit there were no significant biochemical or anthropometric differences at 12-month CMR scan performed at Visit-2 (Table-1).
Over the 12-months period, there was a significant decline in stress-MBF (Visit-1:1.9[1.6,2.2] vs Visit-2:1.4[1.2,2.6]ml/min/g; P=0.006) and MPR (Visit-1:2.8[2.4,3.2] vs Visit-2: 2.3[1.9,2.6]ml/min/g; P=0.04). In parallel with the global perfusion indices, the layer-specific perfusion parameters also showed significant reductions over a 12-month period including the Endo-stress-MBF (Visit-1: 1.7[1.5,2.0] vs Visit-2: 1.2[1.1,1.4]ml/min/g; P=0.0015) and Epi-stress-MBF(Visit-1:2.0[1.7,2.3] vs Visit-2:1.5[1.3,1.7]ml/min/g; P=0.0180)(Figure-1).
Moreover, patients with Mod-AS exhibited a progressive numerical increase in LV concentricity which did not reach statistical significance (Visit-1: 0.74[0.64,0.84] vs Visit-2: 0.84[0.73,0.96]g/mL; P=0.1548). An increasingly restrictive filling pattern was exhibited as measured by E/A ratio (Visit-1: 1.3[1.0,1.5] vs Visit-2: 2.0[1.5,2.6]; P=0.042). While there was no significant change in LV ejection fraction or GLS (Table-2), there was a significant decline in left atrial function (Visit-1: 59[52,66] vs Visit-2:47[41,53]%; P=0.0158). There was also a subtle numerical but non-significant increase in non-ischemic pattern of myocardial scar on LGE (Table-1).
Seven patients progressed to severe-AS, requiring valve intervention at the 18-month censor point. A retrospective subgroup analysis revealed that this group of patients had significantly worse stress-MBF at baseline CMR scan (Mod-AS progressed to Severe-AS:1.6[1.4,1.8], Mod-AS did not progress to Severe-AS:2.0[1.7,2.4]ml/min/g; P=0.0375) compared to patients who did not progress to Severe-AS over the 18-month clinical follow-up period (Table-2).
Conclusion:
Conclusions: Over a period of 12 months, patients with Mod-AS exhibited marked significant deterioration of myocardial perfusion despite less pronounced changes in cardiac concentric hypertrophy and no significant change in LV systolic function on CMR. Patients who progressed to severe-AS over the clinical follow-up period showed worse myocardial perfusion at baseline despite matching AS severity to those who did not progress to severe-AS.